Transforming growth factor-PI (TGF-p,) has been shown to be an injury-related peptide growth factor within the mammalian central nervous system. We tested whether TGF-p, has the capacity to protect rat neocorti cal neurons against excitotoxic damage in vitro and mouse neocortex against ischemic injury in vivo. After 14 days in vitro, cultured neurons from rat cerebral cortex were exposed to 1 mM L-glutamate in serum-free culture medium. The cultures received TGF-p, immediately after the addition of glutamate. Eighteen hours later, the cell viability of the cultures was determined using trypan blue exclusion. TGF-p, (1-10 ng/ml) significantly reduced the excitotoxic neuronal damage in a concentration dependent manner. In vivo, male NMRI mice were sub jected to a permanent occlusion of the left middle cerebral
The transforming growth factors-13 (TGF-l3s) are a family of highly pleiotropic peptide growth fac tors. Beyond their general relevance to the regula tion of normal cellular physiology (Roberts and Sporn, 1990) , the TGF-l3s have been shown to be important mediators of pathophysiological pro cesses such as inflammation and tissue repair (Sporn et aI., 1983; Lefer et aI., 1990; Roberts and Sporn, 1990) . Recently, TGF-132 and TGF-133 mRNAs and proteins have been localized in a wide range of neuronal and glial populations within the rat and mouse central nervous system Unsicker et at., 1991) . The TGF-13 isoform 1, artery by microbipolar electrocoagulation. After 48 h, the animals received a transcardiac injection of carbon black. The area of ischemia (devoid of carbon) was restricted to the neocortex and its size was determined planimetrically by means of an image-analyzing system. The treatment with TGF-p, (1 fLg/kg i.c.v.) at 6, 4, or 2 h prior to vessel occlusion reduced the area of ischemia by 5.3, 10.0, and 9.6%, respectively. The effect of the treatment with TGF PI was statistically significant (p < 0.05 by two-way ANOYA). The present in vitro and in vivo data suggest that TGF-pi has the capacity to diminish the deleterious consequences of an excitotoxic or ischemic insult. Key Words: Transforming growth factor-PI (TGF-pI) Primary neuronal culture-Cerebral cortex-Excitotox icity-Glutamate-Focal cerebral ischemia.
however, seems to be confined to the meningeal cells and the choroid plexus of the normal, unle sioned rodent brain (Flanders et aI., 1991; Unsicker et aI., 1991) . In contrast, there is a high increase in TGF-131 mRNA within the rat hippocampus in re sponse to lesions of the entorhinal cortex, perforant path transections, and kainic acid-induced seizures (Morgan et aI., 1991; Nichols et aI., 1991b) . Klempt (1992) recently demonstrated the induction of TGF-131 mRNA expression within the infant rat brain af ter a hypoxic/ischemic insult.
In view of the possibility that TGF-131 is an injury related peptide growth factor, we tested whether TGF-131 has the capacity to protect neocortical neu rons against excitotoxic damage in vitro and mouse neocortex against ischemic injury in vivo.
MATERIALS AND METHODS

Materials
Purified porcine TGF-131 was obtained from R&D Sys tems (Minneapolis, MN, U.S.A.). Minimum essential me-dium Eagle (MEM; containing Earle's salts, 2 roM L-glu tamine, 5 giL of glucose, and 2.2 giL of sodium bicarbon ate), L-15 Leibovitz medium (containing 2 mM L-glutamine), penicillin-streptomycin solution, and NU serum were obtained from Gibco (Paisely, Scotland). So dium L-glutamate, cytosine I3-D-arabinofuranoside, trypsin inhibitor, papain, and polY-L-lysine hydrobromide (MW 30,000-70,000) were purchased from Sigma (St. Louis, MO, U.S.A.). Carbon black was from Pelikan (Hannover, Germany). All other chemicals used were of analytical grade purity.
Cell culture technique
Mixed neuronaUglial primary cultures were derived from the cerebral cortices of neonatal (P 1) Fischer 344 rats. Under sterile conditions, the neonatal rats were de capitated, and the cerebral cortices were isolated and dis sected. The dissected cortices were treated with papain (0.1 % in L-15 medium Leibovitz) at 37°C for a period of 15 min. The supernatant was removed and the cells were dissociated in MEM containing 10% NU serum by re peated slow pipetting through a fire-polished glass pi pette. After the undispersed tissue pieces had settled, the supernatant was transferred to a second tube and the un dispersed pieces were subjected to another round of trit uration. The supernatants were combined and a trypsin inhibitor solution (1 % in MEM containing 1 % bovine se rum albumin; 20°C) was carefully layered at the bottom. In order to collect the cells, the tube was centrifuged at 400 rpm and 20°C for a period of 10 min. The cells were resuspended in MEM and seeded into polY-L-lysine coated 35 mm Petri dishes (Falcon, Heidelberg, Germany at a final density of 200,000 cells/cm 2 • The cells were grown in MEM supplemented with 10% NU serum, 100 units/ml of penicillin, and 100 /1-g/ml of streptomycin and were kept in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. After 5 days in vitro, the cultures received 10 /1-M cytosine I3-D-arabinofuranoside for a period of 24 h in order to inhibit glial cell prolifera tion. The medium was exchanged every 3-4 days. For the described experiments, we used sister cultures from the same plating.
Glutamate neurotoxicity in rat neocortical cultures
Following a procedure previously described by Koh and Choi (1988) , excitotoxic injury was induced after 14 days in vitro as follows: The cultures were washed twice with serum-free MEM and were then switched to serum free MEM containing 1 roM sodium L-glutamate for a period of 18 h. Cultures that were not exposed to L-glu tamate were also washed twice with serum-free MEM and were then switched to serum-free MEM devoid of glutamate.
Mter 18 h of glutamate exposure, cell viability was determined by means of the trypan blue dye exclusion method. For this purpose, for a period of 5 min, the cul tures were incubated with 0.4% trypan blue, which stains nonviable cells. With a phase contrast microscope, a total number of 400--600 neurons per dish were counted. Only darkly stained neurons that were not phase bright were considered being damaged.
TGF-l3t was dissolved in MEM supplemented with 1 mglml of bovine serum albumin and 4 mM HCl. The growth factor was added to the cultures immediately after the cultures had been switched to the glutamate containing medium, and remained in the cultures until the J Cereb Blood Flow Metab. Vol. 13, No.3, 1993 next day, when the neuronal damage was evaluated. Con trol cultures received the vehicle.
Focal cerebral ischemia in mice
Permanent middle cerebral artery occlusion (MCAO) was performed in male NMRI mice (Savo, Kisslegg, Ger many) by a method modified from that of Welsh et al. (1987) . Briefly, the mice were anesthetized with tribro moethanol (600 mglkg i.p.). An incision was performed between the left orbit and the ear, and the skull was ex posed. With a dental drill, a small hole was made into the outer part of the skull above the translucent MCA. After wards, the inner part of the skull was opened with fine pincettes and the MCA was permanently occluded by mi crobipolar electrocoagulation. Body temperature was maintained at 37°C by an infrared heating lamp during the surgical procedure. Afterwards, the animals were kept at an environmental temperature of 30°C for a period of 2 h in order to avoid cerebral hypothermia (Prehn et al., 1991) . Rectal temperatures were controlled routinely. Af ter this period, the animals were maintained under con trolled light and environmental conditions (12 h darkllight cycle, 23 ± 1°C, 55 ± 5% humidity). A standard diet (Altromin, Lage, Germany) and water were available ad libitum.
After 48 h, the animals were anesthetized again and perfused transcardially with a fine suspension of carbon black. The brains were removed and stored in a fixative (4% formalin in phosphate buffer at pH 7.4) for at least 24 h. The area of ischemia (devoid of carbon) was restricted to the neocortex and its size was planimetrically calcu lated by means of an image-analyzing system (IBAS 2; Kontron, Eching, Germany). In a previous study (Back hauB et al., 1992) , we found a significant correlation (r = 0.81, p < 0.001, n = 62) between the area of ischemia and infarct volume as determined by a standard histological procedure (cresyl violet staining of the sectioned brain). The assessment of the area of ischemia was performed in a blinded fashion by one of the authors (C.B.).
TGF-131 was dissolved as described above and intra cerebroventriculary injected at a single dose of 1 /1-g/kg of body weight (approximately 50 ng/animal) either 6, 4, or 2 h prior to the vessel occlusion. The total volume injected was 100 /1-l. Control animals were treated with 100 /1-1 of the vehicle.
Statistics
All data are given as means ± SD. For statistical com parison, one-way analysis of variance (ANOV A) and post hoc Scheffe's test for multiple comparisons were used for the in vitro study. For the focal ischemia study, two-way ANOV A was performed. The homogeneity of errors was evaluated by Bartlett's test. p values smaller than 0.05 were considered significant.
RESULTS
Glutamate neurotoxicity in rat neocortical cultures
The exposure of the neocortical cultures to the serum-free culture medium containing 1 mM L-glu tamate for a period of 18 h damaged the majority of the cells of the neuronal population. The treatment with TGF-131 during the excitotoxic exposure re duced the neuronal injury in a concentration-dependent manner (Fig. 1) . At a concentration of 3 ng/ml, TGF-�l-treated cultures already reached the values of control cultures that had not been exposed to glutamate.
TGF-�l (10 ng/ml) did not alter the cell viability of cultures that had been exposed to the serum-free medium devoid of glutamate (Fig. 1) .
Focal cerebral ischemia in mice
The pretreatment with TGF-�l (1llg/kg i.c.v.) at 6, 4, or 2 h prior to the induction of the focal isch emia reduced the area of ischemia by 5.3, 10.0, and 9.6%, respectively ( Table 1 ). The overall effect of the pretreatment with TGF-�l was statistically sig nificant (p < 0.05; two-way ANOVA).
DISCUSSION
Neuronal growth and survival are being influ enced by a range of peptide growth factors (Barde, 1989 ), but only few may have neuroprotective prop erties, too. Some growth factors may also be able to stimulate cellular repair mechanisms, which can lead to functional recovery. Growth factors will therefore be important for new strategies for the treatment of cerebral ischemia and neurodegenera tive diseases.
An abnormal activation of glutamate receptors is suggested to play a major role in the pathophysiol ogy of cerebral ischemia and in many types of neu rodegenerative diseases (Choi, 1988) . In the present study, treatment of cultured rat neocortical neurons with the peptide growth factor TGF-�l prevented glutamate-induced neuronal degeneration in a con centration-dependent manner. A pretreatment of the cultures was not required, i.e., TGF-�l was ef fective when added to the cultures during the expo- Permanent MCA occlusion was performed by microbipolar electrocoagulation in male NMRI mice. After 48 h, the animals received a transcardiac injection of carbon black. The area of ischemia (devoid of carbon) was calculated planimetrically by means of an image-analyzing system. The animals received in tracerebroventricular injections of TGF-131 (l ILg/kg) or vehicle either 6, 4, or 2 h prior to vessel occlusion. Data are means ± SD. The overall effect of the pretreatment with TGF-131 was statistically significant (p < 0. 05; two-way analysis of variance).
sure to glutamate only. Intracerebroventricular ad ministration of TGF-�l furthermore reduced the area of ischemia in mice subjected to permanent MCAO. The effect of TGF-�l in vivo was not as pronounced as the effect observed in vitro. Al though the present in vitro and in vivo data cannot be compared directly, the less pronounced effect of TGF-�l in vivo might reflect pharmacokinetic prob lems. At the moment, however, we cannot exclude that the effect of TGF-�l in the model of focal ce rebral ischemia is a consequence of effects of TGF � I on the cerebral vasculature or blood-borne cel lular and humoral elements, rather than a direct ef fect on neurons.
A wide range of lesions, including cerebral isch emiaihypoxia, increase the expression of TGF-�l within the rat central nervous system (Morgan et al., 1991; Nichols et al., 1991a,b; Klempt et al., 1992) , suggesting that TGF-�l plays a role in neu-FIG. 1. TGF-131 protects rat neocortical neu rons from glutamate-induced injury. After 14 days in vitro, the culture medium was replaced by serum-free medium supplemented with 1 mM L-glutamate. Eighteen hours later, the cell via bility of the cultures was determined by using trypan blue exclusion. TGF-131 was added to the cultures immediately after the replacement of the culture medium and was present until the next day, when the neuronal injury was evalu ated. Data are means ± SO from three to four experiments. Different from glutamate-exposed controls: "p < 0.01, "'p < 0.001 by one-way analysis of variance and post hoc Scheffe's test. 10 TGF-p1 (ng/ml) ronal injury and neuronal plasticity. Based on a study in which a model of penetrating brain injury in the rat was used (Lindholm et al., 1992) , and also on a postmortem study of brains of patients with ac quired immune deficiency syndrome (Wahl et al., 1991) , it has been suggested that TGF-�l may derive from penetrating macrophages or activated microg lia. In cultured rat astrocytes, TGF-�l is produced and released upon stimulation with the cytokine in terleukin-1 (da Cunha and Vitkovic, 1992) .
Regarding the biological function of TGF-�l in lesioned brain regions, Logan and co-workers (1991) could demonstrate that TGF-�l neutralizing antibodies reduced astroglial scar formation in duced by cerebral lesions in rats. The present study revealed protective effects of TGF-�l against exci totoxic neuronal injury. It is therefore conceivable that TGF-�l has the function to protect or regener ate vulnerable neurons and, on the other hand, to regulate astrocyte growth and differentiation within the lesioned site.
Numerous reports show that the effects of the TGF-�s on cellular physiology differ from those of growth factors linked to tyrosine kinase activity (re viewed in Roberts and Sporn, 1990) . The TGF-�s indeed mediate a great part of their biological ac tions by interfering with the expression of other growth factors and their receptors.
In cultured rat astrocytes, TGF-�l stimulated the expression of nerve growth factor (NGF), an effect that also was observed in vivo in the rat brain (Lind holm et al., 1990) . In cultured injured rat auditory neurons, TGF-�l enhanced the expression of the fibroblast growth factor (FGF) receptor protein (Lefebvre et al., 1991) . Both NGF and FGF have been shown to reduce excitotoxic damage in cul tured mammaliaI) cortical and hippocampal neurons (Mattson et al., 1989; Cheng and Mattson, 1992) and to protect CAl neurons from ischemic damage caused by transient forebrain ischemia in the Mon golian gerbil (Berlove et al., 1991; Shigeno et al., 1991) . In addition, it has also been demonstrated that TGF-�l enhances its own expression in cul tured rat astrocytes (Lindholm et al., 1990) . How ever, due to the multiple actions of the TGF-�s on cellular physiology and pathophysiology, the pre cise mechanism underlying the protective effect of TGF-�l still has to be elucidated.
In conclusion, the lesion-related peptide growth factor TGF-�l prevented excitotoxic neuronal in jury in rat neocortical cultures and was able to re duce the area of ischemia after permanent MCA occlusion in mice. We suggest that TGF-�l has the function of an endogenous neuroprotectant, a func tion that might be used therapeutically in the treat-J Cereb Blood Flow Metab, Vol. 13, No.3, 1993 ment of ischemic and neurodegenerative diseases of the mammalian central nervous system.
